SLC44A3
Choline transporter-like protein 3
Also known as: CTL3, CTL3_HUMAN, MGC45474
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4M1
- Gene
- SLC44A3
- Ensembl
- ENSG00000143036
- Chromosome
- 1
- Canonical length
- 653 aa
- Protein class
- Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be located in plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
653 residues, UniProt reviewed canonical sequence.
>Q8N4M1|SLC44A3
1 MHCLGAEYLV SAEGAPRQRE WRPQIYRKCT DTAWLFLFFL FWTGLVFIMG YSVVAGAAGR
61 LLFGYDSFGN MCGKKNSPVE GAPLSGQDMT LKKHVFFMNS CNLEVKGTQL NRMALCVSNC
121 PEEQLDSLEE VQFFANTSGS FLCVYSLNSF NYTHSPKADS LCPRLPVPPS KSFPLFNRCV
181 PQTPECYSLF ASVLINDVDT LHRILSGIMS GRDTILGLCI LALALSLAMM FTFRFITTLL
241 VHIFISLVIL GLLFVCGVLW WLYYDYTNDL SIELDTEREN MKCVLGFAIV STGITAVLLV
301 LIFVLRKRIK LTVELFQITN KAISSAPFLL FQPLWTFAIL IFFWVLWVAV LLSLGTAGAA
361 QVMEGGQVEY KPLSGIRYMW SYHLIGLIWT SEFILACQQM TIAGAVVTCY FNRSKNDPPD
421 HPILSSLSIL FFYHQGTVVK GSFLISVVRI PRIIVMYMQN ALKEQQHGAL SRYLFRCCYC
481 CFWCLDKYLL HLNQNAYTTT AINGTDFCTS AKDAFKILSK NSSHFTSINC FGDFIIFLGK
541 VLVVCFTVFG GLMAFNYNRA FQVWAVPLLL VAFFAYLVAH SFLSVFETVL DALFLCFAVD
601 LETNDGSSEK PYFMDQEFLS FVKRSNKLNN ARAQQDKHSL RNEEGTELQA IVRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC44A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- rectum: 33 nTPM
- colon: 30 nTPM
- stomach: 28 nTPM
- kidney: 27 nTPM
- small intestine: 26 nTPM
- pancreas: 26 nTPM
Single-cell type
- somatotrophs: 282 nCPM
- esophageal apical cells: 258 nCPM
- thyrotrophs: 198 nCPM
- distal convoluted tubule cells: 141 nCPM
- tuft cells: 127 nCPM
- enteric stem cells: 122 nCPM
Immune cell
- MAIT T-cell: 1.8 nTPM
- memory CD8 T-cell: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- medulla oblongata: 23 nTPM
- white matter: 17 nTPM
- cerebellum: 16 nTPM
- spinal cord: 16 nTPM
- hypothalamus: 15 nTPM
- midbrain: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC44A3 as an antibody target. Whether an autoantibody or antibody against SLC44A3 could matter depends on whether native SLC44A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC44A3 is annotated at the cell surface, where native SLC44A3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC44A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...